Brief: NanoCarrier cancels cancer medicine licensing and joint development contract with Kowa Company Ltd
Oct 21 (Reuters) - NanoCarrier Co Ltd 4571.T :
* Says the co canceled the licensing for a cancer medicine
NC-6300(K-912) and joint development cooperation contract with
Kowa Company Ltd, which was signed on Sep. 26. 2011
Source text in Japanese:https://goo.gl/DRAjMz
Further company coverage: 4571.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 10 62674724;
Reuters Messaging: jun.cao.reuters.com@reuters.net))